Endoscopic Ultrasonography for Bile Duct and Ampullary Cancer
Author Information
Author(s): Q. L. ZHANG, W. D. NIAN, L. P. ZHANG, J. Y. LIANG
Primary Institution: The First Teaching Hospital, Beijing Medical University
Hypothesis
Endoscopic ultrasonography (EUS) can accurately assess the extent of cancer invasion in ampullary and bile duct carcinoma preoperatively.
Conclusion
EUS is effective for evaluating the extent of cancer invasion in ampullary and bile duct carcinoma but is inadequate for assessing liver metastasis.
Supporting Evidence
- EUS accurately assessed cancer invasion in 82% of ampullary carcinoma cases.
- EUS accurately assessed cancer invasion in 66% of common hepatic duct carcinoma cases.
- EUS accurately assessed cancer invasion in 78% of common bile duct carcinoma cases.
- EUS predicted regional lymph node metastasis with 59% accuracy for ampullary carcinoma.
- EUS predicted regional lymph node metastasis with 56% accuracy for common hepatic duct carcinoma.
- EUS predicted regional lymph node metastasis with 67% accuracy for common bile duct carcinoma.
- EUS detected portal vein invasion in 2 of 3 patients.
- EUS failed to detect liver metastasis in all 3 patients with liver metastasis.
Takeaway
Doctors used a special ultrasound to look at tumors in the bile duct and ampullary area before surgery, and it worked well most of the time, but it couldn't see if the cancer had spread to the liver.
Methodology
Endoscopic ultrasonography was performed on 40 patients with ampullary and bile duct carcinoma to evaluate tumor extent and compare results with histopathological findings.
Limitations
EUS has limited penetration depth, making it inadequate for assessing liver metastasis.
Participant Demographics
22 patients with ampullary carcinoma (15 men, 7 women, mean age 50.4 years) and 18 patients with bile duct carcinoma (10 men, 8 women, mean age 61.2 years).
Want to read the original?
Access the complete publication on the publisher's website